Chemed (NYSE:CHE) Hits New 52-Week High – Time to Buy?

Chemed Corporation (NYSE:CHE) reached a new 52-week high during trading on Thursday . The stock traded as high as $551.74 and last traded at $544.6710, with a volume of 9304 shares traded. The stock had previously closed at $546.51.

Analysts Set New Price Targets

Several brokerages have commented on CHE. Oppenheimer raised their price target on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research note on Friday, July 31st. Bank of America reissued a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Weiss Ratings raised Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Finally, Royal Bank Of Canada boosted their price target on Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 30th. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $530.75.

Chemed Stock Performance

The stock has a market cap of $7.11 billion, a price-to-earnings ratio of 27.26, a PEG ratio of 2.04 and a beta of 0.51. The company’s 50 day simple moving average is $473.28 and its 200 day simple moving average is $438.37. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, topping analysts’ consensus estimates of $5.60 by $0.46. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The company had revenue of $673.25 million during the quarter, compared to analyst estimates of $665.04 million. During the same period in the prior year, the business posted $4.27 EPS. The business’s revenue for the quarter was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, equities research analysts anticipate that Chemed Corporation will post 23.18 earnings per share for the current year.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were given a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date was Thursday, May 28th. Chemed’s dividend payout ratio is 12.05%.

Insider Buying and Selling at Chemed

In other news, Director Andrea R. Lindell sold 1,347 shares of the business’s stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the sale, the director owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. The trade was a 22.73% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Patrick P. Grace sold 190 shares of the company’s stock in a transaction on Friday, July 31st. The shares were sold at an average price of $532.00, for a total value of $101,080.00. Following the completion of the sale, the director owned 3,533 shares of the company’s stock, valued at approximately $1,879,556. This trade represents a 5.10% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 3,537 shares of company stock valued at $1,782,654. 3.33% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the company. Monetary Solutions Ltd acquired a new stake in Chemed in the 4th quarter valued at about $25,000. Los Angeles Capital Management LLC acquired a new position in shares of Chemed in the 4th quarter worth approximately $26,000. BOK Financial Private Wealth Inc. bought a new stake in shares of Chemed in the 4th quarter worth approximately $27,000. Versant Capital Management Inc raised its holdings in shares of Chemed by 7,500.0% in the 2nd quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock worth $35,000 after purchasing an additional 75 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB raised its holdings in shares of Chemed by 65.3% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company’s stock worth $38,000 after purchasing an additional 32 shares in the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.